Description Anti-Factor D, an antibody fragment, is a novel macrophage complement receptor, CRIg (Complement Receptor of the Immunoglobulin superfamily), and is designed to inhibit complement activation and chronic inflammation in tissues.

Development Status A Phase I clinical trial evaluating Anti-Factor D for geographic atrophy associated with dry age-related macular degeneration is ongoing.

Additional Information on Clinical Trials For inquiries about our clinical trials, please submit a request through our information request form or call (888) 662-6728.

National Institutes of Health Website: www.clinicaltrials.gov

November 2009